The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
A High-Density Whole-Genome Association Study Reveals That APOE Is the Major Susceptibility Gene for Sporadic Late-Onset Alzheimer's Disease
Abstract
OBJECTIVE: While the apolipoprotein E (APOE) epsilon allele is a well-established risk factor for late-onset Alzheimer's disease (AD), initial genome scans using microsatellite markers in late-onset AD failed to identify this locus on chromosome 19. Recently developed methods for the simultaneous assessment of hundreds of thousands of single nucleotide polymorphisms (SNPs) promise to help more precisely identify loci that contribute to the risk of AD and other common multigenic conditions. We sought here to demonstrate that more precise identification of loci that are associated with complex, multi-genic genetic disorders can be achieved using ultra-high-density whole-genome associations by demonstrating their ability to identify the APOE locus as a major susceptibility gene for late-onset AD, despite the absence of SNPs within the APOE locus itself, as well as to refine odds ratios (ORs) based on gold-standard phenotyping of the study population. METHOD: An individualized genome-wide association study using 502,627 SNPs was performed in 1086 his-topathologically verified AD cases and controls to determine the OR associated with genes predisposing to Alzheimer's disease. RESULTS: As predicted, ultra-high-density SNP genotyping, in contrast to traditional microsatellite-based genome screening approaches, precisely identified the APOE locus as having a significant association with late-onset AD. SNP rs4420638 on chromosome 19, located 14 kilobase pairs distal to the APOE epsilon variant, significantly distinguished between AD cases and controls (Bonferroni corrected p value = 5.30 x 10(-34), OR = 4.01) and was far more strongly associated with the risk of AD than any other SNP of the 502,627 tested. CONCLUSION: This study provides empirical support for the suggestion that the APOE locus is the major susceptibility gene for late-onset AD in the human genome, with an OR significantly greater than any other locus in the human genome. It also supports the feasibility of the ultra-high-density whole-genome association approach to the study of AD and other heritable phenotypes. These whole-genome association studies show great promise to identify additional genes that contribute to the risk of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, previous studies of clinically and neuropathologically characterized cases and controls may have been too small to demonstrate that APOE2 homozygotes have an even lower OR than the relatively low-risk APOE2/3 group due to the paucity of APOE2 homozygotes, who comprise <1% of the general population1,4.”
From Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) · cites this paper as [1]
In the citing paper
“while the presence of one or two copies of the APOE2 allele is associated with a lower risk of Alzheimer’s dementia and an older mean age at dementia onset1–4.”
From Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) · cites this paper as [1]
In the citing paper
“Compared to the most common APOE3/3 genotype, each additional copy of the APOE4 allele is associated with a higher risk of Alzheimer’s dementia and a younger mean age at dementia onset, such that APOE4 homozygotes are at the highest risk”
From Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) · cites this paper as [1]
In the citing paper
“such that APOE4 homozygotes are at the highest risk”
From Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) · cites this paper as [1]
In the citing paper
“Apolipoprotein E (APOE), the major susceptibility gene for late-onset Alzheimer’s disease (AD), has three common alleles (APOE2, 3, and 4), giving rise to six genotypes (APOE2/2, 2/3, 3/3, 2/4, 3/4, and 4/4).”
From Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) · cites this paper as [1]
In the citing paper
“All have identified strong evidence for association to APOE, but less convincing evidence implicating other genes2 -9 .”
From Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (2009) · cites this paper as [6]
In the citing paper
“The apolipoprotein E4 (APOE4) allele is the most common and important genetic risk factor for late-onset sporadic AD [19–21].”
From 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner (2020) · cites this paper as [19]
In the citing paper
“Apolipoprotein (ApoE) is the major susceptibility gene for the common late-onset form of Alzheimer's disease and the presence of the ε4 allele increases the risk of developing AD [2].”
From Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model (2011) · cites this paper as [2]
In the citing paper
“The first association studies covering most of the genome were published in 2007 [81, 82].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [81]
Citations
Cites
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,563
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857
Prospects for whole-genome linkage disequilibrium mapping of common disease genes
Kruglyak, L. (1999) · Nature Genetics · doi:10.1038/9642 · Cited by 1,416
Staging of Alzheimer-Related Cortical Destruction
Braak, H., Braak, E., & Bohl, J. (2008) · European Neurology · doi:10.1159/000116984 · Cited by 836
Single-Nucleotide Polymorphism Analysis by Pyrosequencing
Ahmadian, A., Gharizadeh, B., Gustafsson, A. C., Sterky, F. H., Nyrén, P., Uhlén, M., & Lundeberg, J. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4493 · Cited by 433
A full genome scan for late onset Alzheimer's disease
Kehoe, P. G. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.2.237 · Cited by 357
Deciphering the Genetic Basis of Alzheimer's Disease
Selkoe, D. J., & Podlisny, M. B. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.022502.103022 · Cited by 303
Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2
Breslow, J. L., Zannis, V. I., SanGiacomo, T. R., Third, J. L., Tracy, T., & Glueck, C. J. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38060-3 · Cited by 174
Cited by
Sorted by citations
Items 301–400 of 572
The impact of growth hormone on proteomic profiles: a review of mouse and adult human studies
Duran‐Ortiz, S., Brittain, A. L., & Kopchick, J. J. (2017) · Clinical Proteomics · doi:10.1186/s12014-017-9160-2 · Cited by 19
Association of TTR polymorphisms with hippocampal atrophy in Alzheimer disease families
Cuenco, K. T., Friedland, R. P., Baldwin, C. T., Guo, J., Vardarajan, B. N., Lunetta, K. L., Cupples, L. A., Green, R. C., DeCarli, C. S., & Farrer, L. A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.02.014 · Cited by 19
APOE Gene polymorphism among Jordanian Alzheimer’s patients with relation to lipid profile
Shafagoj, Y. A., Naffa, R. G., El-Khateeb, M. S., Abdulla, Y. L., Al-qaddoumi, A. A., Khatib, F. A., Yousef, A., & Al-Khateeb, E. M. (2018) · Neurosciences · doi:10.17712/nsj.2018.1.20170169 · Cited by 19
Regan, K., Wang, K., Doughty, E., Li, H., Li, J., Lee, Y., Kann, M. G., & Lussier, Y. A. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000656 · Cited by 18
Genome-wide significant, replicated and functional risk variants for Alzheimer’s disease
Guo, X., Qiu, W., García-Milian, R., Lin, X., Zhang, Y., Cao, Y., Tan, Y., Wang, Z., Shi, J., Wang, J., et al. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1773-0 · Cited by 18
Peripheral transcriptomic biomarkers for early detection of sporadic Alzheimer disease?
Hadar, A., & Gurwitz, D. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.4/dgurwitz · Cited by 18
Bordbar, F., Jensen, J., Du, ., Abied, A., Guo, W., Xu, L., Gao, H., Zhang, L., & Li, J. (2020) · Cell Proliferation · doi:10.1111/cpr.12870 · Cited by 18
Pan, G., King, A. E., Wu, F., Simpson, S., Woodhouse, A., Phipps, A., & Vickers, J. C. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101402 · Cited by 19
Mapping the Genetic-Imaging-Clinical Pathway with Applications to Alzheimer’s Disease
Yu, D., Wang, L., Kong, D., & Hongtu Zhu, B. (2022) · Journal of the American Statistical Association · doi:10.1080/01621459.2022.2087658 · Cited by 18
Alzheimer's disease and related dementias
Hardy, J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139087711.003 · Cited by 18
Self-citationAge-dependent association of KIBRA gene polymorphism with Alzheimer’s disease in Han Chinese
Wang, H.-F., Tan, L., Yu, J., Ma, X., Liu, Q., & Wang, W. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2830-x · Cited by 17
Vitis vinifera: An Alternative for the Prevention of Neurodegenerative Diseases
Pazos-Tomas, C. C., Cruz-Venegas, A., Pérez-Santiago, A. D., Sánchez-Medina, M. ., Matías-Pérez, D., & García-Montalvo, I. A. (2020) · Journal of Oleo Science · doi:10.5650/jos.ess20109 · Cited by 17
Neurogenetic and Neuroepigenetic Mechanisms in Cognitive Health and Disease
Coda, D. M., & Gräff, J. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.589109 · Cited by 17
Gaj, P., Paziewska, A., Bik, W., Dąbrowska, M., Baranowska-Bik, A., Styczyńska, M., Chodakowska-Żebrowska, M., Pfeffer-Baczuk, A., Barcikowska, M., Baranowska, B., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120520 · Cited by 17
Schmidt, C., Becker, H., & Zerr, I. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513505133 · Cited by 17
Yang, Q., Chen, K., Zhang, H., Zhang, W., Gong, C., Zhang, Q., Liu, P., Sun, T., Xu, Y., Qian, X., et al. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-019-00343-2 · Cited by 17
Genetics of Late-Onset Alzheimer’s Disease: Progress and Prospect
Li, Y., & Grupe, A. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.12.1747 · Cited by 17
The Genetics of Alzheimer’s Disease and Parkinson’s Disease
Bekris, L. M., Yu, C., Bird, T. D., & Tsuang, D. W. (2010) · Advances in neurobiology · doi:10.1007/978-1-4419-7104-3_21 · Cited by 16
Unraveling the biological mechanisms in Alzheimer's disease — Lessons from genomics
Borovečki, F., Klepac, N., Mück‐Šeler, D., Hajnšek, S., Mubrin, Z., & Pivac, N. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.019 · Cited by 16
Степанов, В. А., Бочарова, А. В., Marusin, A. V., Жукова, Н. Г., Alifirova, V. M., & Zhukova, I. A. (2014) · Molecular Biology · doi:10.1134/s0026893314060168 · Cited by 16
Bordbar, F., Jensen, J., Zhu, B., Wang, Z., Xu, L., Chang, T., Xu, L., Xu, L., Zhang, L., Gao, H., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223671 · Cited by 16
Ruffini, N., Klingenberg, S., Heese, R., Schweiger, S., & Gerber, S. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.866886 · Cited by 16
The Uniqueness of Biobanks for Neurological and Psychiatric Diseases: Potentials and Pitfalls
Ravid, R. (2014) · Pathobiology · doi:10.1159/000369886 · Cited by 15
Self-citationJiang, X., & Neapolitan, R. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046771 · Cited by 15
Association studies of 22 candidate SNPs with late‐onset Alzheimer's disease
Figgins, J. A., Minster, R. L., Demirci, F. Y., DeKosky, S. T., & Kamboh, M. I. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30851 · Cited by 15
Huang, Y.-H., Chen, Y., Ho, W.-M., Lee, R.-G., Chung, R., Liu, Y., Chang, P.-Y., Chang, S., Wang, C.-W., Chung, W., et al. (2023) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2023.10.021 · Cited by 14
Genetic Risk Score Predicts Late-Life Cognitive Impairment
Wollam, M. E., Weinstein, A. M., Saxton, J. A., Morrow, L. A., Snitz, B. E., Fowler, N. R., Erickson, B. L. S., Roecklein, K. A., & Erickson, K. I. (2015) · Journal of Aging Research · doi:10.1155/2015/267062 · Cited by 14
Missing lnc(RNAs) in Alzheimer’s Disease?
Policarpo, R., & d’Ydewalle, C. V. O. (2021) · Genes · doi:10.3390/genes13010039 · Cited by 14
Fogel, B. L., & Geschwind, D. H. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0434-1.00040-2 · Cited by 14
Streptozotocin mechanisms and its role in rodent models for Alzheimer’s disease
Chik, M. W., Ramli, N. A., Hazalin, N. A. M. N., & Singh, G. K. S. (2022) · Toxin Reviews · doi:10.1080/15569543.2022.2150646 · Cited by 14
Dickson, M. R., Li, J., Wiener, H. W., Perry, R. T., Blacker, D., Bassett, S. S., & Go, R. C. P. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30689 · Cited by 14
APOE is not Associated with Alzheimer Disease: a Cautionary tale of Genotype Imputation
Beecham, G. W., Martin, E. R., Gilbert, J. R., Haines, J. L., & Pericak‐Vance, M. A. (2010) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2010.00573.x · Cited by 14
Decline of fiber tract integrity over the adult age range: A diffusion spectrum imaging study
Teipel, S. J., Lerche, M., Kilimann, I., O’Brien, K., Grothe, M. J., Meyer, P., Li, X., Sänger, P., & Hauenstein, K. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24420 · Cited by 14
Commonalities in the genetics of Alzheimer’s disease and Parkinson’s disease
Grünblatt, E. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.12.1865 · Cited by 14
Impact of gene patents and licensing practices on access to genetic testing for Alzheimer disease
Skeehan, K., Heaney, C. D., & Cook-Deegan, R. M. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181d5a68e · Cited by 13
Jiang, S., Yang, W., Qiu, Y. L., & Chen, H. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150302160145 · Cited by 13
Does APOE explain the linkage of Alzheimer's disease to chromosome 19q13?
Blom, E. S., Holmans, P., Arepalli, S., Adighibe, O., Hamshere, M. L., Gatz, M., Pedersen, N. L., Bergem, A. L. M., Owen, M. J., Hollingworth, P., et al. (2007) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30681 · Cited by 13
Self-citationŠnejdrlová, M., Kalvach, Z., Topinková, E., Vrablı́k, M., Procházková, R., Kvasilová, M., Lánská, V., Zlatohlávek, L., Prusíková, M., & Češka, R. (2011) · PubMed · Cited by 13
Hereditary and sporadic beta-amyloidoses
Fede, G. D. (2013) · Frontiers in bioscience · doi:10.2741/4173 · Cited by 13
Cluett, C., Brayne, C., Clarke, R., Evans, G., Matthews, F., Rubinsztein, D. C., Huppert, F., Llewellyn, D. J., Rice, N., Henley, W., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.020 · Cited by 12
Alzheimer’s disease cortical morphological phenotypes are associated with TOMM40′523-APOE haplotypes
Honea, R. A., Hunt, S. L., Lepping, R. J., Vidoni, E. D., Morris, J. K., Watts, A. S., Michaelis, E. K., Burns, J. M., & Swerdlow, R. H. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.09.001 · Cited by 12
Rodriguez, F. S., Röhr, S., Pabst, A., Kleineidam, L., Fuchs, Â., Wiese, B., Lühmann, D., Brettschneider, C., Wolfsgruber, S., Pentzek, M., et al. (2020) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5409 · Cited by 12
Herring, A., Kurapati, N. K., Krebs, S., Grammon, N., Scholz, L. M., Voss, G., Miah, M. R., Budny, V., Mairinger, F. D., Haase, K., et al. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12687 · Cited by 12
Improving Translational Paradigms in Drug Discovery and Development
Williams, M. J. (2021) · Current Protocols · doi:10.1002/cpz1.273 · Cited by 12
Hays, C. C., Zlatar, Z. Z., Meloy, M. J., Osuna, J., Liu, T. T., Galasko, D. R., & Wierenga, C. E. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190504 · Cited by 12
Korthauer, L. E., Giugliano, R. P., Guo, J., Sabatine, M. S., Sever, P., Keech, A., Atar, D., Kurtz, C., Ruff, C. T., Mach, F., et al. (2022) · PLOS ONE · doi:10.1371/journal.pone.0266615 · Cited by 11
Khandayataray, P., & Murthy, M. K. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.020 · Cited by 11
Apolipoprotein E isoform does not influence trans-synaptic spread of tau pathology in a mouse model
Davies, C., Tulloch, J., Yip, E., Currie, L., Colom‐Cadena, M., Wegmann, S., Hyman, B. T., Wilkins, L., Hooley, M., Tzioras, M., et al. (2023) · Brain and Neuroscience Advances · doi:10.1177/23982128231191046 · Cited by 11
Kumar, S., Yadav, N., Pandey, S., & Thelma, B. K. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0953-5 · Cited by 11
Naj, A. C., Carney, R. M., Hahn, S. E., Slifer, M. A., Haines, J. L., & Pericak‐Vance, M. A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00116-6 · Cited by 11
Ugbaja, S. C., Lawal, M. M., & Kumalo, H. M. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210608145357 · Cited by 11
NMDA Inhibitors: A Potential Contrivance to Assist in Management of Alzheimer’s Disease
Painuli, S., Semwal, P., Zam, W., Taheri, Y., Ezzat, S. M., Zuo, P., Li, L., Kumar, D., Sharifi‐Rad, J., & Martins, N. A. (2022) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207325666220428112541 · Cited by 11
DNMBP is genetically associated with Alzheimer dementia in the Belgian population
Bettens, K., Brouwers, N., Engelborghs, S., Pooter, T. D., Deyn, P. P. D., Sleegers, K., & Broeckhoven, C. V. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.003 · Cited by 11
The SNPs in the human genetic blueprint era
Giampaoli, S., Chillemi, G., Valeriani, F., Lazzaro, D., Borro, M., Gentile, G., Simmaco, M., Zanni, G., Berti, A., & Spica, V. R. (2012) · New Biotechnology · doi:10.1016/j.nbt.2012.11.015 · Cited by 11
Genomic and Proteomic Biomarker Discovery in Neurological Disease
Robeson, R. H., Siegel, A. M., & Dunckley, T. L. (2008) · Biomarker Insights · doi:10.4137/bmi.s596 · Cited by 11
Wang, H., Hsiao, C., Hsieh, A., Lin, Y., & Fann, C. S. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040996 · Cited by 10
Tournier, B. B., Sorce, S., Marteyn, A., Ghidoni, R., Benussi, L., Binetti, G. G., Herrmann, F. R., Krause, K., & Zekry, D. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13392 · Cited by 10
Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer’s Disease
Bhalala, O. G., Watson, R., & Yassi, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25021231 · Cited by 10
Impacts of apolipoprotein E disclosure on healthy Asian older adults: a cohort study
Sng, W. T., Yeo, S. N., Lin, X. B., & Lee, T.-S. W. (2019) · International Psychogeriatrics · doi:10.1017/s1041610218002089 · Cited by 10
Terwilliger, J. D., & Göring, H. H. H. (2009) · Human Biology · doi:10.3378/027.081.0617 · Cited by 10
Pizza, V., Antonini, P., Marino, R., D'Arena, G. F., Lucibello, S. G., Rizzo, M., Brenner, D. A., Jeste, D. V., & Somma, S. D. (2020) · Medicina · doi:10.3390/medicina56050218 · Cited by 10
Biomarkers and Precision Medicine in Alzheimer’s Disease
Sagar, R., Pathak, P., Pandur, B., Kim, S. J., Li, J., & Mahairaki, V. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-78787-5_50 · Cited by 10
Presenilin 1 Polymorphism Associated with Alzheimer’s Disease in Apolipoprotein E4Carriers
Martı́nez-Garcı́a, A., Aldudo, J., Recuero, M., Sastre, I., Cuadrada, E. V., Rosich-Estragó, M., Frank, A., Valdivieso, F., & Bullido, M. J. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000165685 · Cited by 10
Johari, S., Sharma, A. K., Sinha, S., & Das, A. (2019) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2018.12.013 · Cited by 9
Arnal, M., Bini, G., Fernández‐Orth, D., Samaras, E. G., Kassis, M., Aisopos, F., Rambla, J., Paliouras, G., Garrard, P., Giambartolomei, C., et al. (2022) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12300 · Cited by 9
The Genetic Basis of Alzheimer's Disease
Hooli, B. V., & Tanzi, R. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00034-2 · Cited by 9
Kinesin Light Chain 1 Gene Haplotypes in Three Conformational Diseases
von Otter, M., Landgren, S., Nilsson, S., Lundvall, C., Minthon, L., Bogdanović, N., Andreasen, N., Gustafson, D., Skoog, I. G., Wallin, A., et al. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8103-0 · Cited by 9
Kong, F., Wu, T., Dai, J., Cai, J., Zhai, Z., Zhu, Z., Xu, Y., & Sun, T. (2024) · PLoS ONE · doi:10.1371/journal.pone.0295008 · Cited by 8
Mo, C., Peng, Q., Sui, J., Wang, J., Deng, Y., Xie, L., Li, T., He, Y., Qin, X. Y., & Li, S. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-13 · Cited by 8
Importance of GWAS in finding un-targeted genetic association of sporadic Alzheimer’s disease
Bagaria, J., Nho, K. T., & An, S. S. A. (2021) · Molecular & Cellular Toxicology · doi:10.1007/s13273-021-00130-z · Cited by 8
TargetGene: a comprehensive database of cell-type-specific target genes for genetic variants
Lin, S., Wu, S., Zhao, W., Fang, Z., Kang, H., Liu, X., Pan, S., Yu, F., Bào, Y., & Jia, P. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad901 · Cited by 8
Conway, V., Allard, M., Minihane, A. M., Jackson, K. G., Lovegrove, J. A., & Plourde, M. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-148 · Cited by 8
Viana, J. C. A., Valencia, A., Páez, A. L., Montoya, N. E., Palacio, C., Arbeláez, M. P., Berrío, G. B., & Valencia, J. G. (2014) · Revista Colombiana de Psiquiatría · doi:10.1016/j.rcp.2013.11.012 · Cited by 8
Next frontiers in the genetic epidemiology of Alzheimer’s disease
Ikram, M. A., & DeCarli, C. S. (2012) · European Journal of Epidemiology · doi:10.1007/s10654-012-9742-2 · Cited by 8
Cholesterol’s Function and Origin in the Alzheimer’s Disease Brain
Hansen, S. B. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230538 · Cited by 8
Borkowski, K., Liang, N., Zhao, N., Arnold, M., Huynh, K., Karu, N., Mahmoudiandehkordi, S., Kueider-Paisley, A., Kanekiyo, T., Bu, G., et al. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00888-z · Cited by 7
McCoy, N. D., Gawrys, S. P., Mackintosh, S. G., Byrum, S. D., Kosari, N., Zhou, A., Mansoor, M. A. M., Ikeno, Y., Isola, J. V. V., Stout, M. B., et al. (2025) · GeroScience · doi:10.1007/s11357-025-02019-4 · Cited by 7
Gaurón, M. C., Prokopenko, D., Lee, S., Wolfe, S. A., Hecker, J., Willett, J., Waqas, M., Lordén, G., Yang, Y., Mayfield, J. E., et al. (2025) · Science Signaling · doi:10.1126/scisignal.adv0970 · Cited by 7
Medway, C., Shi, H., Bullock, J. M., Black, H. A., Brown, K. S., Vafadar‐Isfahani, B., Matharoo‐Ball, B., Ball, G., Rees, R. C., Kalsheker, N. A., et al. (2010) · PubMed Central · Cited by 7
Sillén, A., Lilius, L., Forsell, C., Kimura, T., Winblad, B. G., & Graff, C. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101359 · Cited by 7
Fish, n-3 Polyunsaturated Fatty Acids, and Cardiovascular Disease
McEvoy, C. T., Young, I. S., & Woodside, J. V. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-894-8_10 · Cited by 7
Adverse selection in a start-up long-term care insurance market
Adams, C. J., Donnelly, C., & Macdonald, A. S. (2014) · British Actuarial Journal · doi:10.1017/s1357321714000270 · Cited by 7
A Multi-Marker Genetic Association Test Based on the Rasch Model Applied to Alzheimer’s Disease
Wang, W., Mandel, J., Bouaziz, J., Commenges, D., Nabirotchkine, S., Chumakov, I. M., Cohen, D., Guedj, M., & Initiative, T. A. D. N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138223 · Cited by 7
Effects of APOE ε2 allele on basal forebrain functional connectivity in mild cognitive impairment
Liu, X., Zeng, Q., Luo, X., Li, K., Xu, X., Hong, L., Li, J., Guan, X., Xu, X., Huang, P., et al. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14038 · Cited by 7
Coon, K. D., Dunckley, T. L., & Stephan, D. A. (2007) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256218 · Cited by 7
Self-citationChoi, Y., Blue, E., Bird, T. D., Steinbart, E. J., Blacker, D., & Wijsman, E. M. (2011) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31220 · Cited by 7
APOE: A Risk Factor for Multiple Disorders
Myers, A., & Nemeroff, C. B. (2012) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e318259b9a5 · Cited by 7
Self-citationChua, A., Thomas, P., Wijesundera, C., Clifton, P. M., & Fenech, M. F. (2014) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21873 · Cited by 6
Li, C., Fuh, J., Yang, B., Hong, C.-J., Chang, C., Tu, P., Jeng, J., Chen, M., Tsai, S., Bai, Y., et al. (2021) · Psychological Medicine · doi:10.1017/s0033291721001070 · Cited by 6
The Genetic Basis of Alzheimer’s Disease
Hooli, B. V., & Tanzi, R. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00002-2 · Cited by 6
Mattsson, P., Forsberg, A., Persson, J., Nyberg, L. H., Nilsson, L., Halldin, C., & Farde, L. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3103-9 · Cited by 6
Genetics of Alzheimer's Disease
Bekris, L. M., Yu, C., Bird, T. D., & Tsuang, D. W. (2010) · Wiley eBooks · doi:10.1002/9780470669600.ch43 · Cited by 6
Hardy, J., & Singleton, A. (2008) · Archives of Neurology · doi:10.1001/archneur.65.3.319 · Cited by 6
Self-citationBeyond proof of principle: new genes for Alzheimer's disease through collaboration
Pericak‐Vance, M. A., & Haines, J. L. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70277-7 · Cited by 6
Examining the statistical properties of fine‐scale mapping in large‐scale association studies
Wiltshire, S., Morris, A. P., & Zeggini, E. (2007) · Genetic Epidemiology · doi:10.1002/gepi.20295 · Cited by 6
Myers, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129013 · Cited by 6
Self-citationA deep belief network-based method to identify proteomic risk markers for Alzheimer diseasePreprint
An, N., Jin, L., Ding, H., Yang, J., & Yuan, J. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2003.05776 · Cited by 6
Association of rare APOE missense variants with Alzheimer's disease in the Japanese population
Miyashita, A., Obinata, A., Hara, N., Mitsumori, R., Kaneda, D., Hashizume, Y., Sano, T., Takao, M., Gabdulkhaev, R., Tada, M., et al. (2025) · Journal of Alzheimer’s Disease · doi:10.1177/13872877251340710 · Cited by 5
Fungwe, T. V., Ngwa, J. S., Johnson, S. P., Turner, J. V., Ramirez-Ruiz, M., Ogunlana, O., Bedada, F. B., Nadarajah, S., Ntekim, O. E., & Obisesan, T. O. (2023) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000528117 · Cited by 5
Nanostructure-Based Molecules as Diagnostic and Theranostic Tools in Alzheimer’s Disease
Suthar, T., & Jain, K. (2023) · Springer eBooks · doi:10.1007/978-981-99-6038-5_6 · Cited by 5
Metadata
- Authors
- Coon, K. D., Myers, A. J., Craig, D. W., Webster, J. A., Pearson, J. V., Lince, D. H., Zismann, V. L., Beach, T. G., Leung, D., Bryden, L., Halperin, R. F., Marlowe, L., Kaleem, M., Walker, D. G., Ravid, R., Heward, C. B., Rogers, J., Papassotiropoulos, A., Reiman, E. M., Hardy, J., & Stephan, D. A.
- Affiliations
- Translational Genomics Research Institute (US)
- University of Miami (US)
- Banner Sun Health Research Institute (US)
- National Institutes of Health (US)
- ORCID
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2007-04-15
- Volume
- 68
- Issue
- 04
- Pages
- 613-618
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2017581860
- Cited by
- 569
- References
- 15
- Citations by year
- 2026: 4 · 2025: 18 · 2024: 15 · 2023: 37 · 2022: 32 · 2021: 26 · 2020: 23 · 2019: 23 · 2018: 28 · 2017: 20 · 2016: 21 · 2015: 22 · 2014: 29 · 2013: 28 · 2012: 42
- FWCI
- 36.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- National Institute on Aging (U01AG016976)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- late-onset Alzheimer's disease, apolipoprotein E, genetic susceptibility, single nucleotide polymorphisms, whole-genome association studies, chromosome 19, odds ratio, genetic susceptibility loci
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Brain, Chromosome Mapping, Chromosomes, Human, Pair 19, Female, Humans, Male, Risk Factors, Odds Ratio, Case-Control Studies, Age of Onset, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
